hydroxymethanediphosphonic acid has been researched along with Bone Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogova, S; Chauchat, P; Kerrou, K; Michaud, L; Nataf, V; Ohnona, J; Paycha, F; Talbot, JN | 1 |
| Aronen, HJ; Auren, J; Huovinen, R; Jambor, I; Kajander, S; Kauppila, E; Kemppainen, J; Kuisma, A; Merisaari, H; Minn, H; Noponen, T; Ramadan, S; Sandell, M; Saunavaara, J; Seppänen, M | 1 |
| Hsieh, BT; Hsieh, JF; Lin, WY; Ting, G; Tsai, SC; Wang, SJ | 1 |
| Kajiyama, H; Kanai, H; Kuroiwa, T; Maezawa, A; Naruse, T; Nojima, Y; Ueki, K; Yano, S | 1 |
| Balikdjian, D; Frühling, J; Verbist, A | 1 |
1 trial(s) available for hydroxymethanediphosphonic acid and Bone Cancer
| Article | Year |
|---|---|
Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Diphosphonates; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Sensitivity and Specificity; Sodium Fluoride; Technetium; Time Factors | 2013 |
4 other study(ies) available for hydroxymethanediphosphonic acid and Bone Cancer
| Article | Year |
|---|---|
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sensitivity and Specificity; Technetium Compounds | 2016 |
Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Etidronic Acid; Injections, Intravenous; Isotope Labeling; Neoplasm Metastasis; Organometallic Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Soft Tissue Neoplasms; Tissue Distribution; Whole-Body Counting | 1999 |
Hypercalcemia induced by metastatic bone cancer in a patient with chronic renal failure.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Ribs; Tamoxifen; Technetium; Tomography, X-Ray Computed | 2000 |
Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Diagnostic Tests, Routine; Diphosphonates; Drug Evaluation; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate | 1986 |